awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35923834-F2F332C9-B2F3-4B7A-BCC0-4F4D8E90C872
Q35923834-F2F332C9-B2F3-4B7A-BCC0-4F4D8E90C872
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35923834-F2F332C9-B2F3-4B7A-BCC0-4F4D8E90C872
Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration.
P2860
Q35923834-F2F332C9-B2F3-4B7A-BCC0-4F4D8E90C872
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35923834-F2F332C9-B2F3-4B7A-BCC0-4F4D8E90C872
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b09186aadd5abfd9e3eddbc120038c71cd8a8078
P2860
Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results.